Latest Cryopreservation Stories
Independent, Comparative Evaluation by Leading Research Centers in Germany and Portugal Indicates Significant Biopreservation Advantages of Serum-Free, Pre-Formulated CryoStor BOTHELL, Wash., March 10 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissue, and organs, today announced that an independent European comparison of the Company's...
BOTHELL, Wash., Jan. 26 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary GMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced the launch of its new quarterly newsletter BioPreservation Today, a forum for sharing knowledge about optimizing biopreservation protocols and processes, to maximize the yield and function of cells and tissues in research and...
Internal Manufacturing Scale-Up Underway to Support Increased Product Demand BOTHELL, Wash., Jan. 26 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary GMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced record revenue for the fourth quarter and full year 2008 and also the receipt of $1.4 million in funding for operations and the completion of construction and...
BOTHELL, Wash., Dec. 29 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has joined the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, an international consortium of leading scientific, clinical, and commercial partners whose mission is to explore collaborative ways to improve...
Additional Safety Data Could Drive Product Adoption in High-Growth Cell Therapy Market BOTHELL, Wash., Dec. 16 /PRNewswire-FirstCall/ --BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has completed an initial series of small animal safety studies at the Seattle-based Fred Hutchinson Cancer Research Center on its...
A fully automated process is set to improve the production of artificial tissue: medical scientists can perform transplants with skin produced in the laboratory. This tissue is also suitable for testing chemicals at a low cost without requiring animal experiments.Some patients wish they had a second skin "“ for instance because their own skin has been burnt in a severe accident. But transplanting skin is a painstaking task, and a transplant that has to cover large areas often requires...
BOTHELL, Wash., Dec. 8 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has been granted a European patent for an application that includes claims related to protecting cells from injury and death caused by cold temperatures used in biopreservation. The patent titled, "Inclusion of Apoptotic...
ROCKLAND, Mass., Nov. 7 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA of Darmstadt, Germany, announced the launch of the Human Oocyte Preservation Experience (HOPE) Registry surrounding next week's 64th Annual Meeting of the American Society for Reproductive Medicine (ASRM). The HOPE Registry is the only comprehensive national patient registry in the United States designed to study the safety and efficacy of oocyte cryopreservation procedures, commonly known as egg freezing....
Japanese scientists said on Monday they have created clones from the bodies of mice that have been frozen for 16 years.The researchers said it might even be possible to use the technique to resurrect mammoths and other extinct species.Teruhiko Wakayama and colleagues at the Center for Developmental Biology, at Japan's RIKEN research institute in Yokohama, were able to clone the mice even though their cells had burst.The team wrote: "Thus, nuclear transfer techniques could be used to...
NEW YORK, Oct. 24 /PRNewswire/ -- The day of true reproductive freedom for women has arrived. A new scientific study confirms the efficacy of a revolutionary egg selection and freezing process that, at long last, offers women a viable and reliable fertility preservation option. Developed and clinically tested by the scientists at ReproCure, a vanguard genetics products company, this process increases the live births derived from a cryopreserved egg almost seven-fold over the field's current...
